• The University of Texas at San Antonio
  • myUTSA
    • ASAP
    • Blackboard
    • Staff Webmail
    • Libraries
  • Info For
    • Students
    • Faculty
    • Staff
    • Parents
    • Visitors
  • Maps
    • Main
    • Downtown
    • Hemisfair Park
  • Directory
  • Calendar
  • About UTSA
  • facilitating growth, enabling productivity, pursuing excellence
  • Home
  • About UTSA Research
  • For Researchers
  • For Partners
  • For Students
  • Research News
  • Contact Us

Commentary: Infectious disease research needs more investment

December 16, 2020

By Bernard Arulanandam, For the Express-News Dec. 13, 2020

As a COVID-19 vaccine is being rolled out, we should all have a greater appreciation of immunological memory, the primary rationale for the development of vaccines against infectious microbes. The basis for immunological memory can be traced back to the ancient Greeks and the plague of that time, when survivors of the infection did not experience the disease again and were often called upon to nurse the afflicted individuals.

This early observation led to the concept of inoculation or variolation, which became a common practice in certain parts of the world and was introduced to Europe around the 18th century through the Royal Society. Lady Mary Wortley Montague was responsible for leading variolation in England where in 1722 the daughters of the Prince of Wales were inoculated.

Just a year prior, in 1721, the practice of variolation had reached the colonies when inoculation against smallpox was championed by the Rev. Cotton Mather and Dr. Zabdiel Boylston, a great uncle of President John Adams.

In 1796 country doctor Edward Jenner made a seminal observation that dairymaids who were exposed to cowpox never came down with smallpox. This observation led to the concept of vaccination, and these findings were published in 1798.

In 1840 vaccination replaced the practice of variolation, and in 1977 the World Health Organization led a global effort to successfully eradicate smallpox. A similar worldwide immunization effort with two different vaccine platforms (akin to the different COVID vaccines) led to the suppression of polio in the 1960s. Similar successes around the world are evident by several efforts, including Gavi, the Vaccine Alliance, which provides critical childhood vaccines in the world’s poorest countries and prevents millions of deaths.

Immunologic memory and specificity are important characteristics of learned or adaptive immunity, where the immune system remembers antigens from past exposure and launches a robust immune response when the same antigen is seen again. These features of the immune system are intrinsic in humans and form the basis for the development of vaccines against microbes that have historically caused epidemics and transformed society.

The pressing need for further investments in infectious disease research is evident by the ease of global travel, the rise of world population, human behavior, and changes to climatic patterns with spread of insect vectors that have impacted microbial ecology and transmission patterns of infectious microorganisms.


EXPLORE FURTHER
⇒ Bernard Arulanandam’s research activity at UTSA
⇒ UTSA’s Office of Research, Economic Development, and Knowledge Enterprise

The current pandemic has amplified the power of international coordination and cooperation. The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published in early January 2020. This catalyzed research and development into the generation of promising vaccines for mass production in under a year.

Such innovation will further spur opportunities in the design of next-generation vaccine platforms for evolving future major public health concerns that will be at the forefront of public attention and collaborative private-government action.

Filed Under: General, Research News

Research News
Academy Fellows Speaker Series
Knowledge Enterprise Newsletter
Discovery Magazine external link icon
  • gallery quick link icon Media Gallery

Current Issue:

2015 Volume 8

Past Issues

Research, Scholarship, and Creative Achievement at UTSA

Office of the Vice President for Research, Economic Development and Knowledge Enterprise
  • Home
  • Sitemap
  • Contact
  • facebook icon
  • twitter icon
  • youtube icon
to top icon
UTSA
  • Sitemap
  • Campus Maps
  • Jobs
  • Campus Alerts
  • Policies
  • Open Records
  • Report Fraud
  • Required Links
  • Identity
  • UT System
  • Contact Us

© The University of Texas at San Antonio | One UTSA Circle, San Antonio TX 78249 | Information: 210-458-4011 | UTSA Police: 210-458-4242